What ‘unbelievable demand’ for weight-loss drugs adds up to for maker Lilly – Firstpost
 "What ‘unbelievable demand’ for weight-loss drugs adds up to for maker Lilly – Firstpost")
Increased manufacturing capacity for Eli Lilly’s highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by $3 billion on Thursday, and its share jumped as much as 14 per cent. Lilly also raised its 2024 profit forecast and said sales of Zepbound crossed $1 billion for the first time … Read more
